INS and type 1 diabetes mellitus: Accordingly, for T1D pilot results from the Pre-POINT study, the first study to administer daily oral insulin to children at risk to develop T1D, but before the start of the autoimmune reaction, resulted in enhanced frequencies of insulin-specific CD4+ T cells with regulatory features (24).